EPCAM and neoplasm: Consistent with these findings, the migration and invasion abilities of isolated Thy1+ CAFs and CD326+ tumor cells, as well as the expression of activation markers of the related signaling pathways in CD326+ tumor cells and of CAFs, were attenuated by injection of ApoSQ-CAF CM.